In vitro dendritic cell infection by pseudotyped adenoviral vectors does not correlate with their in vivo immunogenicity
- PMID: 15661134
- DOI: 10.1016/j.virol.2004.11.014
In vitro dendritic cell infection by pseudotyped adenoviral vectors does not correlate with their in vivo immunogenicity
Abstract
Expression of antigens in dendritic cells (DC) can stimulate protective immunity against both viral infection and tumor growth, making them important targets for gene therapy. In-vitro-generated DC are commonly used in gene delivery studies with the assumption that the results will correlate with in vivo activity. Adenovirus Type 5 (Ad5) vectors have been widely used with DC, but these cells lack the primary receptor (CAR) used by Ad5 and are poorly infected. We investigated the use of Ad5 vector particles pseudotyped with fibers from other Ad serotypes in DC targeting. Several fiber proteins, including those from Ad16 (Subgroup B) and Ad37 (Subgroup D), conferred dramatically increased in vitro infection. Surprisingly, neither dendritic cell infection nor the immune response to an Ad-delivered antigen was improved when the modified viruses were tested in vivo. These results underscore the importance of using appropriate animal models in gene delivery studies.
Similar articles
-
An adenoviral type 5 vector carrying a type 35 fiber as a vaccine vehicle: DC targeting, cross neutralization, and immunogenicity.Vaccine. 2004 Aug 13;22(23-24):3035-44. doi: 10.1016/j.vaccine.2004.02.011. Vaccine. 2004. PMID: 15297053
-
Sensitization to enhanced green fluorescence protein minor histocompatibility antigen by gene transduction into dendritic cells and peritoneal exudate macrophages.Transpl Immunol. 2007 Nov;18(2):73-84. doi: 10.1016/j.trim.2007.04.003. Epub 2007 Jun 6. Transpl Immunol. 2007. PMID: 18005848
-
Transduction with a fiber-modified adenoviral vector is superior to non-viral nucleofection for expressing tumor-associated Ag mucin-1 in human DC.Cytotherapy. 2006;8(1):36-46. doi: 10.1080/14653240500508166. Cytotherapy. 2006. PMID: 16627343
-
Immune responses against adenoviral vectors and their transgene products: a review of strategies for evasion.Crit Rev Oncol Hematol. 2004 Apr;50(1):51-70. doi: 10.1016/S1040-8428(03)00172-0. Crit Rev Oncol Hematol. 2004. PMID: 15094159 Review.
-
DNA viruses and genetic modification of dendritic cells.Arch Immunol Ther Exp (Warsz). 2002;50(4):273-7. Arch Immunol Ther Exp (Warsz). 2002. PMID: 12371623 Review.
Cited by
-
CD46-utilizing adenoviruses inhibit C/EBPbeta-dependent expression of proinflammatory cytokines.J Virol. 2005 Sep;79(17):11259-68. doi: 10.1128/JVI.79.17.11259-11268.2005. J Virol. 2005. PMID: 16103178 Free PMC article.
-
The attenuation of vaccinia Tian Tan strain by the removal of the viral M1L-K2L genes.J Virol Methods. 2007 Sep;144(1-2):17-26. doi: 10.1016/j.jviromet.2007.03.012. Epub 2007 Apr 24. J Virol Methods. 2007. PMID: 17459491 Free PMC article.
-
Tropism-modification strategies for targeted gene delivery using adenoviral vectors.Viruses. 2010 Oct;2(10):2290-2355. doi: 10.3390/v2102290. Epub 2010 Oct 13. Viruses. 2010. PMID: 21994621 Free PMC article.
-
Lysosomal localization and mechanism of membrane penetration influence nonenveloped virus activation of the NLRP3 inflammasome.Virology. 2011 Apr 10;412(2):306-14. doi: 10.1016/j.virol.2011.01.019. Epub 2011 Feb 18. Virology. 2011. PMID: 21315400 Free PMC article.
-
Myeloid and plasmacytoid dendritic cells are susceptible to recombinant adenovirus vectors and stimulate polyfunctional memory T cell responses.J Immunol. 2007 Aug 1;179(3):1721-9. doi: 10.4049/jimmunol.179.3.1721. J Immunol. 2007. PMID: 17641038 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
